Celebrating 10 Years of Progress

Now in its 10th year, CHI’s Immunogenicity & Bioassay Summit will examine the challenges currently facing the industry and will provide NEW case studies, NEW perspectives and NEW approaches. You will hear from the industry, academia and the regulatory authorities. This year we present 3 Conference Programs, a Symposium, Training Seminar and many short courses for in-depth study, as well as interactive breakout discussions for sharing of experiences and ideas, and excellent networking opportunities.

Join us at the #1 Immunogenicity & Bioassay Event in the U.S.
Bringing Together Industry, Academia & Regulatory Authorities

EVENT FEATURES:

• 65+ Scientific Presentations & Case Studies, including FDA
• Roundtable Breakouts & Panel Discussions
• Dedicated Exhibit/Poster Hall
• "Track-hop" to Conferences Occurring on the Same Dates
• 250+ Global Delegates Attended in 2017

Testimonials

“This conference provides very deep and broad scientific presentations, roundtable discussions, and excellent networking opportunities for scientists, managers/directors, CROs, vendors and consultants.”
- Senior Group Leader, Pfizer

“The Immunogenicity and Bioassay Summit covers up-to-date research and regulatory advances on all aspects of immunogenicity. It’s a very good meeting for experts and newcomers to the field.”
- Senior Director, Head, Bioanalytical and Biomarker Development, Research & Nonclinical Development, Shire

“Program and participants first class.”
- Associate Director, Novo Nordisk

“Great to get regulatory perspectives on challenges and expectations. The higher level strategic discussions were very informative.”
- Beth Arnold, Director, Biologics & Vaccine Bioanalytics, Merck

“Breakout interaction with FDA experts was very valuable.”
- Associate Director, Alexion Pharmaceuticals Inc.

“The event has a great atmosphere for networking and learning about new expectations in our always changing field”
- Senior Group Leader, Immunogenicity, PPD, Inc.

“I really liked the wide and deep background provided by the highly specialized speakers. Everyone in the field should attend this."
- Post-Doctoral Fellow, Molecular Biology, National Cancer Institute

View more testimonials

Keynote & Featured Speakers

Rakesh Dixit, PhD
Vice President, R&D, Global Head, Biologics Safety Assessment
MedImmune, Inc.

Theresa Goletz, PhD
Global Head NBE DD
EMD Serono

William Hallett, PhD
Biologist, OPQ/OBP
CDER, FDA

Timothy Hickling, PhD
Immunogenicity Sciences Lead, Biomedicine Design
Pfizer, Inc.

Thomas Little, PhD
President and CEO, Bioassay Sciences
Thomas A. Little Consulting

Ira Pastan, MD
Co-Chief, Molecular Biology, National Cancer Institute
National Institutes of Health

Timothy Schofield
Senior Advisor, Technical Research & Development
GSK

Ethan Shevach, MD
Senior Investigator, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
NIH

Perceval Sondag
Senior Manager, Statistics
PharmaLex

Joleen T. White, PhD
Director, Head of Project Support, NBE Drug Disposition
EMD Serono

Contact Us

SPEAKER AND TOPIC SUGGESTIONS
Nicole Lyscom, PhD
Sr. Conference Director and Team Lead,
Cambridge Healthtech Institute
Phone: +44 1935 389498
Email: nlyscom@healthtech.com

SPONSORSHIP & EXHIBITS
Carolyn Benton
Business Development Manager,
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email: cbenton@healthtech.com